{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:56:09Z","timestamp":1785704169725,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009047","name":"Strategic Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005878","name":"Research Council for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.actbio.2026.06.061","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:39:11Z","timestamp":1782851951000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-8031","authenticated-orcid":false,"given":"Iuliia","family":"Pilipenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-2765","authenticated-orcid":false,"given":"Katja","family":"Stenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooseppi","family":"Puranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Toropainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iida","family":"M\u00e4\u00e4tt\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-7790","authenticated-orcid":false,"given":"Michael","family":"Jeltsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0630-8175","authenticated-orcid":false,"given":"Suvi","family":"Jauhiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7398-8298","authenticated-orcid":false,"given":"Tiina","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna P.","family":"Laakkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Scurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-9450","authenticated-orcid":false,"given":"Tapani","family":"Viitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-4333","authenticated-orcid":false,"given":"Astrid","family":"Subrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.06.061_bib0001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-015-0455-8","article-title":"Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis","volume":"13","author":"Bertrand","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.actbio.2026.06.061_bib0002","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.06.061_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124877","article-title":"Novel strategies in systemic and local administration of therapeutic monoclonal antibodies","volume":"667","author":"Pra\u0161nikar","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.06.061_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.actbio.2026.06.061_bib0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/03639045.2025.2494126","article-title":"Thermosensitive chitosan hydrogel loaded cetuximab: a novel approach for parenteral controlled delivery","volume":"51","author":"Abdellatif","year":"2025","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.actbio.2026.06.061_bib0006","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2147\/JPR.S283518","article-title":"Intraarticular injection of Infliximab-loaded thermosensitive hydrogel alleviates pain and protects cartilage in rheumatoid arthritis","volume":"Volume 13","author":"Chen","year":"2020","journal-title":"J. Pain Res. Volume"},{"key":"10.1016\/j.actbio.2026.06.061_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.03.050","article-title":"Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies","volume":"323","author":"Chung","year":"2020","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2026.06.061_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2017.12.019","article-title":"Antibody loaded collapsible hyaluronic acid hydrogels for intraocular delivery","volume":"124","author":"Egbu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2026.06.061_bib0009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bm2009558","article-title":"Extended release of Bevacizumab by thermosensitive biodegradable and biocompatible hydrogel","volume":"13","author":"Wang","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.06.061_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","article-title":"Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery","volume":"82","author":"Kabanov","year":"2002","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2026.06.061_bib0011","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1021\/acsomega.0c02009","article-title":"In situ forming injectable thermoresponsive hydrogels for controlled delivery of biomacromolecules","volume":"5","author":"Dutta","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.actbio.2026.06.061_bib0012","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1021\/acs.langmuir.3c00088","article-title":"Engineering the structure and rheological properties of P407 hydrogels via reverse poloxamer addition","volume":"39","author":"White","year":"2023","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2026.06.061_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.procir.2015.11.001","article-title":"Pluronic F127 hydrogel characterization and biofabrication in cellularized constructs for tissue engineering applications","volume":"49","author":"Gioffredi","year":"2016","journal-title":"Procedia CIRP"},{"key":"10.1016\/j.actbio.2026.06.061_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.carbpol.2016.08.068","article-title":"Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery","volume":"156","author":"Jung","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2026.06.061_bib0015","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1021\/acs.biomac.5c00292","article-title":"Thermoresponsive hydrogels with tunable viscoelasticity for extended ocular drug delivery","volume":"26","author":"Pilipenko","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.06.061_bib0016","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor\u20093\u2009(Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/pro.3986","article-title":"In-depth interrogation of protein thermal unfolding data with MoltenProt","volume":"30","author":"Kotov","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0018","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1107\/S2059798321008998","article-title":"eSPC: an online data-analysis platform for molecular biophysics","volume":"77","author":"Burastero","year":"2021","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"10.1016\/j.actbio.2026.06.061_bib0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/protein\/5.3.191","article-title":"Quantitative analysis of protein far UV circular dichroism spectra by neural networks","volume":"5","author":"B\u00f6hm","year":"1992","journal-title":"Prot. Eng."},{"key":"10.1016\/j.actbio.2026.06.061_bib0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/bjc.2016.275","article-title":"A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer","volume":"115","author":"Wentink","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2026.06.061_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105720","article-title":"Pharmacokinetics of intravitreal macromolecules: scaling between rats and rabbits","volume":"159","author":"Sadeghi","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0022","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/19420862.2016.1259046","article-title":"Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira\u00ae","volume":"9","author":"Magnenat","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.actbio.2026.06.061_bib0023","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1042\/BCJ20200568","article-title":"New insights on the interaction mechanism of rhTNF\u03b1 with its antagonists Adalimumab and Etanercept","volume":"477","author":"Contreras","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.actbio.2026.06.061_bib0024","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2003.013052","article-title":"Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed","volume":"63","author":"van de Putte","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.actbio.2026.06.061_bib0025","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus Verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.06.061_bib0026","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.06.061_bib0027","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","article-title":"Light-activated, In situ forming gel for sustained suprachoroidal delivery of Bevacizumab","volume":"10","author":"Tyagi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2026.06.061_bib0028","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin1 to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.06.061_bib0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/bm501063n","article-title":"Formulation of In situ chemically cross-linked hydrogel depots for protein release: from the blob model perspective","volume":"16","author":"Yu","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.06.061_bib0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2015.07.029","article-title":"Single-injection vaccines: progress, challenges, and opportunities","volume":"219","author":"McHugh","year":"2015","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2026.06.061_bib0031","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","article-title":"Intravitreal hydrogels for sustained release of therapeutic proteins","volume":"326","author":"Ilochonwu","year":"2020","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2026.06.061_bib0032","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.biomaterials.2010.12.023","article-title":"Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies","volume":"32","author":"Guziewicz","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.06.061_bib0033","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1021\/acs.iecr.5b01193","article-title":"Complexation hydrogels as oral delivery vehicles of therapeutic antibodies: an in vitro and ex vivo evaluation of antibody stability and bioactivity","volume":"54","author":"Carrillo-Conde","year":"2015","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.actbio.2026.06.061_bib0034","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of Intravitreal Bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2026.06.061_bib0035","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of Bevacizumab after topical, subconjunctival, and intravitreal administration in Rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0036","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1167\/iovs.15-17457","article-title":"Evaluation of fluorophotometry to assess the vitreal pharmacokinetics of protein therapeutics","volume":"56","author":"Dickmann","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202203402","article-title":"Yield-stress and creep control depot formation and persistence of injectable hydrogels following subcutaneous administration","volume":"32","author":"Jons","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2026.06.061_bib0038","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1167\/iovs.08-3125","article-title":"Enzymatic breakdown of type II collagen in the Human vitreous","volume":"50","author":"van Deemter","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2026.06.061_bib0039","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3109\/02713689608995150","article-title":"Human vitreous hyaluronidase: isolation and characterization","volume":"15","author":"Schwartz","year":"1996","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.actbio.2026.06.061_bib0040","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1021\/acs.jproteome.5c00208","article-title":"Quantifying hydrolytic enzymes in the vitreous humor of humans and nonhuman species using targeted proteomics","volume":"24","author":"Ruttenberg","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.actbio.2026.06.061_bib0041","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.biomaterials.2004.02.067","article-title":"Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern","volume":"26","author":"Segura","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.06.061_bib0042","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.actbio.2023.09.025","article-title":"Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina","volume":"171","author":"Lee","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.06.061_bib0043","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jconrel.2022.10.036","article-title":"Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space","volume":"352","author":"Jung","year":"2022","journal-title":"J. Control. Rel."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126004344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126004344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:29:40Z","timestamp":1785702580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126004344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S1742706126004344"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.061","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thermoresponsive hydrogel for long-acting delivery of structurally intact and biologically active Fab fragment and monoclonal antibody","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}